<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 S1438 IS: Allowing Greater Access to Safe and Effective Contraception Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2015-05-21</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>114th CONGRESS</congress><session>1st Session</session><legis-num>S. 1438</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20150521">May 21, 2015</action-date><action-desc><sponsor name-id="S340">Ms. Ayotte</sponsor> (for herself, <cosponsor name-id="S377">Mr. Gardner</cosponsor>, <cosponsor name-id="S376">Mrs. Ernst</cosponsor>, <cosponsor name-id="S300">Mr. Burr</cosponsor>, <cosponsor name-id="S345">Mr. Johnson</cosponsor>, <cosponsor name-id="S384">Mr. Tillis</cosponsor>, and <cosponsor name-id="S352">Mr. Heller</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSFI00">Committee on Finance</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To allow women greater access to safe and effective contraception.</official-title></form>
	<legis-body>
 <section id="id8E295F7339FD4239B16C9ABB2E50BDC8" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Allowing Greater Access to Safe and Effective Contraception Act</short-title></quote>.</text> </section><section id="id2c6df2d69599416aa77c5f0cae7e43d4"><enum>2.</enum><header>Applications for non-prescription contraceptive drugs</header> <subsection id="id73B59BB60F2F4B9BB9889EB2C60D0165"><enum>(a)</enum><header>Priority review of application</header><text>The Secretary of Health and Human Services (referred to in this section as the <quote>Secretary</quote>) shall give priority review to any supplemental application submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355">21 U.S.C. 355(b)</external-xref>) for a contraceptive drug, provided that—</text>
 <paragraph id="idFAAB1BF4C2EF458FAEB6FB215BC50EF6"><enum>(1)</enum><text>the supplemental application is with respect to a drug intended for routine use; and</text> </paragraph><paragraph id="idFD315D13E0B4418C843761C7D727D845"><enum>(2)</enum><text>if the supplemental application is approved, with respect to individuals aged 18 and older, such drug would not be subject to section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/353">21 U.S.C. 353(b)(1)</external-xref>).</text>
 </paragraph></subsection><subsection id="id95DC521A29664BF88F7E11C186A0D13A"><enum>(b)</enum><header>Fee waiver</header><text>The Secretary shall waive the fee under section 736(a)(1) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/379h">21 U.S.C. 379h(a)(1)</external-xref>) with respect to a supplemental application that receives priority review under subsection (a).</text>
 </subsection><subsection id="id622EACE330AB4B8C88263493F0AB3719"><enum>(c)</enum><header>Over-the-Counter availability</header><text>Notwithstanding any other provision of law, with respect to individuals under age 18, a contraceptive drug that is eligible for priority review under subsection (a) shall be subject to section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/353">21 U.S.C. 353(b)(1)</external-xref>).</text>
			</subsection></section><section id="idb2146befc18d434996a238768ffed51a"><enum>3.</enum><header>Empowering women to make their own health decisions</header>
 <subsection id="id72c99ef8b3e24cdc91af7c5df07857cf"><enum>(a)</enum><header>No limitations based on whether a drug is prescribed</header><text>Section 9003 of the Patient Protection and Affordable Care Act (<external-xref legal-doc="public-law" parsable-cite="pl/111/148">Public Law 111–148</external-xref>), and the amendments made by such section, are repealed, and the Internal Revenue Code of 1986 shall be applied as if such section, and amendments, had never been enacted.</text>
 </subsection><subsection id="ida72df4c0993d4a0698f87d2ac317884d"><enum>(b)</enum><header>No limitations on health FSAs</header><text>Sections 9005 and 10902 of the Patient Protection and Affordable Care Act (<external-xref legal-doc="public-law" parsable-cite="pl/111/148">Public Law 111–148</external-xref>) and section 1403 of the Health Care and Education Reconciliation Act of 2010 (<external-xref legal-doc="public-law" parsable-cite="pl/111/152">Public Law 111–152</external-xref>), and the amendments made by such sections, are repealed, and the Internal Revenue Code of 1986 shall be applied as if such sections, and amendments, had never been enacted.</text>
			</subsection></section></legis-body></bill>


